Clinical Trial

Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Study of hysteroscopic repeat curettage as the first-line treatment in low-risk postmolar gestational trophoblastic neoplasia compared with the MTX single drug chemotherapy
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-10-09; most recent amendment 2026-06-28.
Status change: Not Yet Recruiting → Recruiting 2019-04-26
Trial Details
NCT Number NCT03703271
Lead Sponsor Women's Hospital School Of Medicine Zhejiang University
Collaborators: Sun Yat-sen University, Huazhong University of Science and Technology, Qilu Hospital of Shandong University
Conditions Gestational Trophoblastic Neoplasia
Enrollment 70 participants
Start Date 2019-03-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-01